Abildtrup M, Shattock M (2013) Cardiac Dysautonomia in Huntington’s disease. J Huntingtons Dis 2:251–261

Article  PubMed  Google Scholar 

Achenbach J, Faissner S, Saft C (2021) Differential diagnosis of chorea-hiv infection delays diagnosis of Huntington’s disease by years. Brain Sci 11:710

Bacos K, Björkqvist M, Petersén A, Luts L, Maat-Schieman ML, Roos RA, Sundler F, Brundin P, Mulder H, Wierup N (2008) Islet beta-cell area and hormone expression are unaltered in Huntington’s disease. Histochem Cell Biol 129:623–629

Article  CAS  PubMed  Google Scholar 

Bai D, Deng F, Jia Q, Ou K, Wang X, Hou J, Zhu L, Guo M, Yang S, Jiang G, Li S, Li XJ, Yin P (2024) Pathogenic TDP-43 accelerates the generation of toxic exon1 HTT in Huntington’s disease knock-in mice. Aging Cell 23:e14325

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baskota SU, Lopez OL, Greenamyre JT, Kofler J (2019) Spectrum of Tau pathologies in Huntington’s disease. Lab Invest 99:1068–1077

Article  CAS  PubMed  Google Scholar 

Bellosta Diago E, Pérez-Pérez J, Santos Lasaosa S, Viloria Alebesque A, Martínez-Horta S, Kulisevsky J, Del López J (2018) Neurocardiovascular pathology in pre-manifest and early-stage Huntington’s disease. Eur J Neurol 25:956–962

Article  CAS  PubMed  Google Scholar 

Blum D, Herrera F, Francelle L, Mendes T, Basquin M, Obriot H, Demeyer D, Sergeant N, Gerhardt E, Brouillet E, Buée L, Outeiro TF (2015) Mutant Huntingtin alters Tau phosphorylation and subcellular distribution. Hum Mol Genet 24:76–85

Article  CAS  PubMed  Google Scholar 

Boesgaard TW, Nielsen TT, Josefsen K, Hansen T, Jørgensen T, Pedersen O, Nørremølle A, Nielsen JE, Hasholt L (2009) Huntington’s disease does not appear to increase the risk of diabetes mellitus. J Neuroendocrinol 21:770–776

Article  CAS  PubMed  Google Scholar 

Bragina EY, Gomboeva DE, Saik OV, Ivanisenko VA, Freidin MB, Nazarenko MS, Puzyrev VP (2023) Apoptosis genes as a key to identification of inverse comorbidity of Huntington’s disease and cancer. Int J Mol Sci 24:9385

Brás IC, König A, Outeiro TF (2019) Glycation in Huntington’s disease: a possible modifier and target for intervention. J Huntingtons Dis 8:245–256

Article  PubMed  PubMed Central  Google Scholar 

Breza M, Emmanouilidou E, Leandrou E, Kartanou C, Bougea A, Panas M, Stefanis L, Karadima G, Vekrellis K, Koutsis G (2020) Elevated serum alpha-synuclein levels in Huntington’s disease patients. Neuroscience 431:34–39

Article  CAS  PubMed  Google Scholar 

Canosa A, Cabras S, Di Pede F, Manera U, Vasta R, Moglia C, Calvo A, Gallone S, Chiò A (2024) A mother and her daughter carrying a pathogenic expansion of the HTT gene with a phenotype encompassing motor neuron disease and Huntington’s disease. Clin Genet 105:430–433

Article  CAS  PubMed  Google Scholar 

Cardoso F (2017) Autoimmune choreas. J Neurol Neurosurg Psychiatry 88:412–417

Article  PubMed  Google Scholar 

Cattaneo E, Barker RA (2024) Brain cholesterol therapy for Huntington’s disease - Does it make sense? Clin Transl Med 14:e1746

Article  PubMed  PubMed Central  Google Scholar 

Chang KH, Cheng ML, Lo CJ, Fan CM, Wu YR, Chen CM (2023) Alternations of lipoprotein profiles in the plasma as biomarkers of Huntington’s disease. Cells 12:385

Charles V, Mezey E, Reddy PH, Dehejia A, Young TA, Polymeropoulos MH, Brownstein MJ, Tagle DA (2000) Alpha-synuclein immunoreactivity of Huntingtin polyglutamine aggregates in striatum and cortex of Huntington’s disease patients and Transgenic mouse models. Neurosci Lett 289:29–32

Article  CAS  PubMed  Google Scholar 

Chatzikonstantinou S, Dagklis I, Kazis D, Karantali E, Bostantjopoulou S (2019) Huntington’s disease with comorbid myasthenia Gravis: a case report. Hippokratia 23:28–29

CAS  PubMed  PubMed Central  Google Scholar 

Chhetri SK, Dayanandan R, Bindman D, Craufurd D, Majeed T (2014) Amyotrophic lateral sclerosis and Huntington’s disease: neurodegenerative link or coincidence? Amyotroph Lateral Scler Frontotemporal Degener 15:145–147

Article  PubMed  Google Scholar 

Cho K, Kim GW (2025) Decreased SREBP2 of the striatal cell relates to disrupted protein degradation in Huntington’s disease. Brain Res 1846:149250

Article  CAS  PubMed  Google Scholar 

Coarelli G, Diallo A, Thion MS, Rinaldi D, Calvas F, Boukbiza OL, Tataru A, Charles P, Tranchant C, Marelli C, Ewenczyk C, Tchikviladzé M, Monin ML, Carlander B, Anheim M, Brice A, Mochel F, Montcel S, Humbert S, Durr A (2017) Low cancer prevalence in polyglutamine expansion diseases. Neurology 88:1114–1119

Article  CAS  PubMed  Google Scholar 

Dai L, Zou L, Meng L, Qiang G, Yan M, Zhang Z (2021) Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Mol Neurobiol 58:2183–2201

Article  CAS  PubMed  Google Scholar 

Davis MY, Keene CD, Jayadev S, Bird T (2014) The co-occurrence of Alzheimer’s disease and Huntington’s disease: a neuropathological study of 15 elderly Huntington’s disease subjects. J Huntingtons Dis 3:209–217

Article  CAS  PubMed  Google Scholar 

Davis M, Wheelock V, Talman L, Latimer C, Vicars B, Lin A, Jayadev S, Bird T (2021) Subdural hematoma as a serious complication of Huntington’s disease: an observational study. J Huntingtons Dis 10:385–390

Article  CAS  PubMed  Google Scholar 

del Toro D, Xifró X, Pol A, Humbert S, Saudou F, Canals JM, Alberch J (2010) Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington’s disease. J Neurochem 115:153–167

Article  PubMed  Google Scholar 

Drouin-Ouellet J, Sawiak SJ, Cisbani G, Lagacé M, Kuan WL, Saint-Pierre M, Dury RJ, Alata W, St-Amour I, Mason SL, Calon F, Lacroix S, Gowland PA, Francis ST, Barker RA, Cicchetti F (2015) Cerebrovascular and blood-brain barrier impairments in Huntington’s disease: potential implications for its pathophysiology. Ann Neurol 78:160–177

Article  PubMed  Google Scholar 

Evers S, Stögbauer F (2003) Genetic association of Huntington’s disease and restless legs syndrome? A family report. Mov Disord 18:225–227

Article  PubMed  Google Scholar 

Farrer LA (1985) Diabetes mellitus in huntington disease. Clin Genet 27:62–67

Article  CAS  PubMed  Google Scholar 

Feinstein E, Walker R (2020) Treatment of secondary chorea: a review of the current literature. Tremor Other Hyperkinet Mov (N Y) 10:22

Article  PubMed  Google Scholar 

Ferreira JJ, Rodrigues FB, Duarte GS, Mestre TA, Bachoud-Levi AC, Bentivoglio AR, Burgunder JM, Cardoso F, Claassen DO, Landwehrmeyer GB, Kulisevsky J, Nirenberg MJ, Rosser A, Roth J, Seppi K, Slawek J, Furr-Stimming E, Tabrizi SJ, Walker FO, Vandenberghe W, Costa J, Sampaio C (2022) An MDS evidence-based review on treatments for Huntington’s disease. Mov Disord 37:25–35

Article  PubMed  Google Scholar 

Furby H, Moore S, Nordstroem AL, Houghton R, Lambrelli D, Graham S, Svenningsson P, Petersén Å (2023) Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington’s disease: a study of linked Swedish National registries (2002–2019). J Neurol 270:864–876

Article  PubMed  Google Scholar 

Gao X, Campbell WAt, Chaibva M, Jain P, Leslie AE, Frey SL, Legleiter J (2016) Cholesterol modifies Huntingtin binding to, disruption of, and aggregation on lipid membranes. Biochemistry 55:92–102

Article  CAS  PubMed  Google Scholar 

Gomboeva DE, Bragina EY, Nazarenko MS, Puzyrev VP (2020) Comorbidity between oncological diseases and Huntington’s disease: review of epidemiological and biological evidence. Russ J Genet 56:269–279 DOI 210.1134/S1022795420030059

Article  CAS  Google Scholar 

González-Guevara E, Cárdenas G, Pérez-Severiano F, Martínez-Lazcano JC (2020) Dysregulated brain cholesterol metabolism is linked to neuroinflammation in Huntington’s disease. Mov Disord 35:1113–1127

Article  PubMed  Google Scholar 

Haghikia A, Décard BF, Hellwig K, Kraus P, Gold R (2012) Wheels within wheels: multifocal autoimmune myelitis in a woman with Huntington’s disease. J Neurol 259:1973–1975

Article  PubMed